Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART and risperidone for adolescent aggression
NL-OMON36647Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of risperidone in conduct disorder (CD), oppositional defiant disorder (ODD), intermittent explosive disorder (IED) and 1 more (4 arms), sponsored by Radboud University Medical Center. Started Oct 2011; status: active, not recruiting.
02
Drugs
risperidone
03
Conditions
conduct disorder (CD)oppositional defiant disorder (ODD)intermittent explosive disorder (IED)disruptive behavior disorder not otherwise specified (DBD-NOS)
Beyond the preview
Go deeper on NL-OMON36647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36647.